The FDA on Tuesday gave Ozempic a thumbs-up to reduce the risk of kidney disease worsening, kidney failure and death from cardiovascular disease in adult type 2 diabetes patients who also have chronic kidney disease. More: Novo Nordisk expands Ozempic's
read moreThe newly approved PI3K inhibitor helped patients live longer in the pivotal INAVO120 study, adding to the drug’s previously reported progression-free survival win. More: Roche's breast cancer entrant Itovebi bolsters clinical profile with overall survival win Source: fierce
read more
Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25 More: Cartesian Therapeutics announces FDA agreement for new trial Source: News
read more
Patients and care partners may find once every four weeks maintenance dosing easier More: FDA approves new Alzheimer’s treatment regimen Source: News
read moreAmgen reached a settlement with Celltrion, putting a bout of patent litigation to bed and allowing the South Korean company to launch its biosimilar versions of Amgen’s bone blockbusters Prolia and Xgeva as early as June 1. The settlement appears
read moreUnder an executive order, the United States Agency for International Development is temporarily prohibited from delivering lifesaving drugs to its partner countries. More: Trump's foreign aid freeze threatens global HIV, malaria drug supply from USAID: reports Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals